Perspective
Published on 15 Sep 2022
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.940582
- 2,059 views
- 2 citations
Type at least 3 characters
1,009 articles
Articles
Original Research
Published on 15 Sep 2022
A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.974614
- 3,461 views
- 7 citations
Review
Published on 15 Sep 2022
Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.971288
- 9,137 views
- 18 citations
Original Research
Published on 14 Sep 2022
Icariin attenuates the tumor growth by targeting miR-1-3p/TNKS2/Wnt/β-catenin signaling axis in ovarian cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.940926
- 2,807 views
- 12 citations
Original Research
Published on 14 Sep 2022
A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.932156
- 1,915 views
- 4 citations
Original Research
Published on 14 Sep 2022
The efficacy and safety of 125I brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.992399
- 1,046 views
Correction
Published on 13 Sep 2022
Corrigendum: The role of NR4A1 in the pathophysiology of osteosarcoma: A comprehensive bioinformatics analysis of the single-cell RNA sequencing dataset
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1027056
- 1,399 views
Editorial
Published on 13 Sep 2022
Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1005381
- 751 views
- 2 citations
Brief Research Report
Published on 12 Sep 2022
Further investigation of blockade effects and binding affinities of selected natural compounds to immune checkpoint PD-1/PD-L1
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.995461
- 2,900 views
- 5 citations
Mini Review
Published on 12 Sep 2022
Deconvoluting the complexity of autophagy in colorectal cancer: From crucial pathways to targeted therapies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1007509
- 2,160 views
- 3 citations
Review
Published on 12 Sep 2022
Targeted and cellular therapies in lymphoma: Mechanisms of escape and innovative strategies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.948513
- 5,504 views
- 4 citations
Case Report
Published on 12 Sep 2022
Case report: ZEB1 expression in three cases of hepatic carcinosarcoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.972650
- 1,850 views
Review
Published on 08 Sep 2022
Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathways
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.956793
- 5,722 views
- 10 citations
Review
Published on 08 Sep 2022
The recent advances of cancer associated fibroblasts in cancer progression and therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.1008843
- 5,329 views
- 7 citations
Review
Published on 05 Sep 2022
Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.978603
- 2,642 views
- 3 citations
Mini Review
Published on 05 Sep 2022
Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.955163
- 4,226 views
- 13 citations